WhaleQuant.io
Viatris Inc. (VTRS) Corporate Logo

Viatris Inc. (VTRS) Stock Price & Analysis

Market: NASDAQ • Sector: Healthcare • Industry: Drug Manufacturers - Specialty & Generic

Viatris Inc. (VTRS) Profile & Business Summary

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Key Information

Ticker VTRS
Exchange NASDAQ
Official Site https://www.viatris.com
CIK Number 0001792044
View SEC Filings

Market Trend Overview for VTRS

One model, two time views: what the market looks like right now, and where the larger trend is heading over time.

Longer-Term Market Trend (Mid to Long Term)

Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-11-17 (ET)

As of 2026-11-17, VTRS is moving sideways without a clear direction. Over the longer term, the trend remains bullish.

VTRS last closed at 20.45. The price is about 0.8 ATR above its recent average price (20.00), and the market is currently in a sideways market without a clear direction. Price at 20.45 is moving between minor support near 20.39 and minor resistance near 21.26. Direction remains unclear. View Support & Resistance from Options

The market is moving sideways, with no clear direction. Both upside and downside risks remain in play.

Trend Alignment Summary

Trend score: 35 out of 100. Overall alignment is unclear. The market is currently in a sideways market without a clear direction. The longer-term trend is still positive, but short-term signals are not yet confirming it.

Key Risk Level

A key downside risk boundary is near 17.93. If price falls below this area, the current structure would likely weaken further.

Recent Trend Signal

A systematic trend-activation signal was most recently triggered on 2026-10-16, reflecting a technical shift toward positive directional alignment.

Unusual Price Movement

[2026-10-27] Price moved quickly and looked strong, but participation was limited.

Recent Price Behavior

Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.

Overnight Positioning

Closing activity showed limited conviction and did not suggest strong overnight positioning.

Price Stretch Risk

As of 2026-11-11, price has extended significantly above its primary volume area, entering a liquidity-thin zone. While the uptrend remains intact, the risk of chasing strength has increased.

Next-day directional probability forecast Last updated: 2026-11-17 (ET)
Next-session outlook for 2026-11-18 (ET)
No clear next-day edge

What the model sees

The model stays neutral because the setup is not clear enough to justify a directional deployment.


Why the model says this

The model does not deploy this setup because predictability is still too low and recent price behavior has shown failed reversal memory. Predictability is 36%, agreement is 73%, and reversal risk is 16%.

NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history

Recent Cost Distribution Last updated: 2026-11-17 (ET)

This estimate uses 1-minute price, volume, and VWAP data from the last 55 trading days, with turnover-based decay. The sample period is 2026-09-01 to 2026-11-17. The current price is 20.45, 11.10% above the estimated average cost of 18.41. An estimated 86.3% of recent positioning is below the current price, while 12.6% is above it. The peak-density price is 19.12. The largest concentrated cost region is 16.91 to 17.77 and contains 28.9% of the estimated distribution. The current price is within the 20.43 to 20.51 cost region. The nearest region below the current price is 18.95 to 19.15. The nearest region above the current price is 20.75 to 20.87.

Short Interest & Covering Risk for VTRS

This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.

Squeeze Score 0.56

Shows how likely a short squeeze may be under current market conditions.

Key Market Risk Indicators
Short Crowding (Short Interest / Float) 3.15%
Short Positions Trend Not Increasing
Liquidity Trend (Average Daily Volume) 5.14%
20-Day Return 9.65%
Price vs 20-Day High Below Recent Highs

Short Exposure Percentile

Short interest is within its typical range, with no clear imbalance between buyers and sellers. (Historical percentile: 58%)

Structure Analysis

VTRS Short positioning looks normal. Current days to cover is 4.0 trading days, meaning short positions could unwind at a normal pace. Short covering is likely to have a normal impact on price moves. No meaningful structural fragility is currently detected (Fragility Score 6/100, DTC percentile 70%) while price maintains a mild upward bias (20D return 9.7%).

Risk Summary

No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.

Why Price Reactions May Be Stronger?

Price action is compressing (range is tightening), which can make breaks more sensitive. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 1× larger than usual.


Note: Short interest data is reported every two weeks by FINRA. The most recent snapshot is 2026-10-30 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.

Analytical Modules